Merck & Co Inc

Country

United States

Sector

Healthcare

Industry

Drug Manufacturers - General

Employees

73,000

Ticker

MRK

Exchange

NEW YORK STOCK EXCHANGE, INC.

Website

www.merck.com

Description

Merck & Co., Inc. is a prominent player in the global pharmaceutical industry. It is primarily focused on the research, development, production, and marketing of drugs and vaccines. Known for its stro... Show more

Financial Statements of Merck & Co Inc

Below are the financial statements of Merck & Co Inc, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in billions of USD	2024	2023
Current assets	—	—
Cash and cash equivalents	13.24^a	6.84^a
Short-term investments	0.45^a	0.25^a
Accounts receivable (net of allowance for doubtful accounts of $89 in 2024 and $88 in 2023)	10.28^a	10.35^a
Inventories (excludes inventories of $4,193 in 2024 and $3,348 in 2023 classified in other assets)	6.11^a	6.36^a
Other current assets	8.71^a	8.37^a
Total current assets	38.78^a	32.17^a
Assets	—	—
Investments	0.46^a	0.25^a
Property, plant and equipment (at cost)	—	—
Land	0.31^a	0.33^a
Buildings	16.36^a	14.97^a
Machinery, equipment and office furnishings	18.28^a	17.76^a
Construction in progress	7.98^a	8.26^a
Less: accumulated depreciation	19.16^a	18.27^a
Goodwill	21.67^a	21.2^a
Other intangibles, net	16.37^a	18.01^a
Other assets	16.04^a	12^a
Current liabilities	—	—
Loans payable and current portion of long-term debt	2.65^a	1.37^a
Trade accounts payable	4.08^a	3.92^a
Accrued and other current liabilities	15.69^a	15.77^a
Income taxes payable	3.91^a	2.65^a
Dividends payable	2.08^a	1.99^a
Total current liabilities	28.42^a	25.69^a
Liabilities and equity	—	—
Long-term debt	34.46^a	33.68^a
Deferred income taxes	1.39^a	0.87^a
Other noncurrent liabilities	6.47^a	8.79^a
Merck & Co., Inc. stockholders’ equity	—	—
Common stock	1.79^a	1.79^a
Other paid-in capital	44.7^a	44.51^a
Retained earnings	63.07^a	53.9^a
Accumulated other comprehensive loss	-4.95^a	-5.16^a
Less treasury stock, at cost	58.3^a	57.45^a
Total Merck & Co., Inc. stockholders’ equity	46.31^a	37.58^a
Noncontrolling interests	0.06^a	0.05^a
Total equity	46.37^a	37.64^a

Verified Sources Behind Merck & Co Inc’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Merck & Co Inc’s data sources below and access millions more through our Disclosure Search.

a. Merck & Co Inc's 10-K 2024

Trace every data point back to Merck & Co Inc’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Merck & Co Inc

Financial Statements of Merck & Co Inc

Verified Sources Behind Merck & Co Inc’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Organon & Co

Biogen Inc

Gilead Sciences Inc

Stryker Corp

Danaher Corp

Molina Healthcare Inc